Rockefeller Financial Services’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$23K Sell
141
-400
-74% -$71.8K ﹤0.01% 465
2017
Q3
$111K Buy
541
+400
+284% +$93K ﹤0.01% 378
2017
Q2
$34K Hold
141
﹤0.01% 395
2017
Q1
$34K Hold
141
﹤0.01% 416
2016
Q4
$30K Hold
141
﹤0.01% 439
2016
Q3
$32K Hold
141
﹤0.01% 409
2016
Q2
$33K Sell
141
-128
-48% -$29.5K ﹤0.01% 416
2016
Q1
$72K Sell
269
-49
-15% -$14K ﹤0.01% 389
2015
Q4
$99K Sell
318
-1,130
-78% -$336K ﹤0.01% 390
2015
Q3
$394K Buy
1,448
+1,430
+7,944% +$439K 0.01% 271
2015
Q2
$5K Sell
18
-261
-94% -$77.8K ﹤0.01% 444
2015
Q1
$83K Buy
279
+99
+55% +$28.2K ﹤0.01% 394
2014
Q4
$46K Buy
+180
New +$45K ﹤0.01% 389

Other funds holding AGN

Rockefeller Financial Services's AGN Position: Q4 2017 in Review

Rockefeller Financial Services reduced its Allergan plc (AGN) stake by 74% in Q4 2017, selling an estimated $71.8K and leaving 141 shares worth $23K. The position accounts for ﹤0.01% of the portfolio, ranked #465.

Rockefeller Financial Services first reported a position in AGN in Q4 2014 and has held it in 13 quarters since. The position peaked at $394K in Q3 2015. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • Rockefeller Financial Services held 141 shares of Allergan plc worth $23K as of Q4 2017.
  • Rockefeller Financial Services sold 400 Allergan plc shares in Q4 2017, an estimated $71.8K.
  • Allergan plc made up ﹤0.01% of Rockefeller Financial Services's portfolio in Q4 2017, its #465 holding.
  • Rockefeller Financial Services first reported a position in Allergan plc in Q4 2014 and has held it in 13 quarters since.
  • Rockefeller Financial Services's Allergan plc position peaked at $394K in Q3 2015.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Rockefeller Financial Services's 13F filing for Q4 2017, filed 2 Feb 2018.